Prothena Corp PLC (PRTA)
20.57
-0.43
(-2.05%)
USD |
NASDAQ |
Apr 18, 16:00
20.60
+0.03
(+0.15%)
After-Hours: 20:00
Prothena SG&A Expense (Quarterly): 16.94M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.94M |
September 30, 2023 | 16.64M |
June 30, 2023 | 14.51M |
March 31, 2023 | 13.74M |
December 31, 2022 | 13.12M |
September 30, 2022 | 11.99M |
June 30, 2022 | 12.95M |
March 31, 2022 | 11.84M |
December 31, 2021 | 12.21M |
September 30, 2021 | 11.96M |
June 30, 2021 | 11.03M |
March 31, 2021 | 11.12M |
December 31, 2020 | 9.908M |
September 30, 2020 | 9.398M |
June 30, 2020 | 9.656M |
March 31, 2020 | 9.741M |
December 31, 2019 | 8.059M |
September 30, 2019 | 8.691M |
June 30, 2019 | 9.081M |
March 31, 2019 | 9.905M |
December 31, 2018 | 8.026M |
September 30, 2018 | 9.235M |
June 30, 2018 | 10.99M |
March 31, 2018 | 14.23M |
Date | Value |
---|---|
December 31, 2017 | 14.04M |
September 30, 2017 | 12.44M |
June 30, 2017 | 10.91M |
March 31, 2017 | 10.83M |
December 31, 2016 | 9.604M |
September 30, 2016 | 16.14M |
June 30, 2016 | 8.134M |
March 31, 2016 | 7.182M |
December 31, 2015 | 6.629M |
September 30, 2015 | 5.905M |
June 30, 2015 | 5.522M |
March 31, 2015 | 5.049M |
December 31, 2014 | 5.011M |
September 30, 2014 | 4.23M |
June 30, 2014 | 4.937M |
March 31, 2014 | 4.873M |
December 31, 2013 | 5.269M |
September 30, 2013 | 3.389M |
June 30, 2013 | 3.212M |
March 31, 2013 | 3.181M |
December 31, 2012 | 2.962M |
September 30, 2012 | 2.082M |
June 30, 2012 | 2.427M |
March 31, 2012 | 2.458M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
8.059M
Minimum
Dec 2019
16.94M
Maximum
Dec 2023
11.72M
Average
11.84M
Median
Mar 2022
SG&A Expense (Quarterly) Benchmarks
Amarin Corp PLC | 43.94M |
Jazz Pharmaceuticals PLC | 396.03M |
Iterum Therapeutics PLC | 1.687M |
GH Research PLC | 2.837M |
Mural Oncology PLC | 16.27M |